Parimifasor
CAS No. 1796641-10-5
Parimifasor ( LYC-30937-EC;LYC30937 )
Catalog No. M12714 CAS No. 1796641-10-5
Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 51 | In Stock |
|
5MG | 87 | In Stock |
|
10MG | 132 | In Stock |
|
25MG | 267 | In Stock |
|
50MG | 394 | In Stock |
|
100MG | 582 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameParimifasor
-
NoteResearch use only, not for human use.
-
Brief DescriptionParimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
-
DescriptionParimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).Psoriasis Phase 2 Clinical
-
SynonymsLYC-30937-EC;LYC30937
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
IndicationPsoriasis
Chemical Information
-
CAS Number1796641-10-5
-
Formula Weight460.21
-
Molecular FormulaC18H11Cl2F4N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥150 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(/N=C(NC1=CC(F)=CC(Cl)=C1)\NC2=NNC(C(F)(F)F)=C2)C3=CC=CC(Cl)=C3
-
Chemical Name3-chloro-N-[(3-chloro-5-fluoroanilino){[5-(trifluoromethyl)-1H-pyrazol-3-yl]amino}methylidene]benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Aka Lumine
AkaLumine is a luciferin analogue.
-
Methyl 3-methoxyacry...
Methyl 3-methoxyacrylate is a natural product for research related to life sciences.
-
Epoxomicin
Epoxomicin is a selective proteasome inhibitor with anti-inflammatory activity, inhibits primarily the CH-L activity of the 20S proteasome.